Literature DB >> 26038346

Association of the interleukin-6 polymorphisms with systemic lupus erythematosus: a meta-analysis.

Y X Cui1, C W Fu1, F Jiang1, L X Ye1, W Meng2.   

Abstract

BACKGROUND: Interleukin (IL)-6, an important proinflammatory cytokine, plays a potential pathological role in systemic lupus erythematosus (SLE). Studies on the relationship of IL-6 gene polymorphisms with SLE are inconclusive. The aim of this study was to estimate the relationship more precisely.
METHODS: The databases of PubMed and Web of Science updated to 30 August 2014 were retrieved. Meta-analysis was conducted using allelic contrast, dominant, recessive and homozygote contrast models. Fifteen studies were included in this study and ethnicity-specific meta-analysis was performed on European, Iranian and Asian populations.
RESULTS: Analysis for the IL-6-174 G/C polymorphism under all models except the homozygote contrast model indicated an association in the overall population (allelic contrast model: odds ratio (OR) 1.428, 95% confidence interval (CI) 1.124-1.812, dominant model: OR 1.382, 95% CI 1.037-1.842, recessive model: OR 1.610, 95% CI 1.158-2.240, homozygote contrast model: OR 1.759, 95% CI 0.989-3.127), as well as in European individuals under all four genetic models (allelic contrast model: OR 1.557, 95% CI 1.155-2.098, dominant model: OR 1.699, 95% CI 1.203-2.400, recessive model: OR 1.506, 95% CI 1.176-1.930, homozygote contrast model: OR 2.118, 95% CI 1.103-4.065). Analysis for the IL-6-572 G/C polymorphism indicated significant association in overall ethnicities under the recessive model (OR 1.491, 95% CI 1.104-2.014), but not under other models or in Asian individuals. In addition, significant association between the IL-6-174 G/C polymorphism and discoid skin lesions and antinuclear antibodies (ANAs) were found under the allelic contrast model and recessive model, respectively (discoid skin lesions: OR 2.271, 95% CI 1.053-4.895; ANAs: OR 2.244, 95% CI 1.141-4.416).
CONCLUSION: This meta-analysis provides evidence of the association between the IL-6 polymorphism and the risk of SLE, hinting that the IL-6-174 G/C and IL-6-572 G/C polymorphisms may play a role in SLE susceptibility.
© The Author(s) 2015.

Entities:  

Keywords:  Interleukin-6; meta-analysis; polymorphism; systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 26038346     DOI: 10.1177/0961203315588971

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

1.  Association between rs1800795 polymorphisms in the interleukin-6 gene and vasculitis: A meta-analysis.

Authors:  Jae Hyun Jung; Hongdeok Seok; Sung Jae Choi; Gwan Gyu Song; Youngjin Han
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  T cell help in the autoreactive germinal center.

Authors:  Elliot H Akama-Garren; Michael C Carroll
Journal:  Scand J Immunol       Date:  2022-05-31       Impact factor: 3.889

3.  The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus.

Authors:  Hua-Tuo Huang; Jian-Ming Chen; Jing Guo; Yan Lan; Ye-Sheng Wei
Journal:  Rheumatol Int       Date:  2016-01-14       Impact factor: 2.631

Review 4.  Immunogenetics of cutaneous lupus erythematosus.

Authors:  Aimee O Hersh; Lisa M Arkin; Sampath Prahalad
Journal:  Curr Opin Pediatr       Date:  2016-08       Impact factor: 2.856

Review 5.  Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus.

Authors:  Ji Yang; Xue Yang; Hejian Zou; Ming Li
Journal:  Oxid Med Cell Longev       Date:  2016-08-11       Impact factor: 6.543

6.  Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: A PRISMA-compliant meta-analysis.

Authors:  Hui-Ling Liang; Shu-Juan Ma; Hong-Zhuan Tan
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 7.  Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus.

Authors:  Chang-Youh Tsai; Chieh-Yu Shen; Hsien-Tzung Liao; Ko-Jen Li; Hui-Ting Lee; Cheng-Shiun Lu; Cheng-Han Wu; Yu-Min Kuo; Song-Chou Hsieh; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

Review 8.  Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype.

Authors:  Fulvia Ceccarelli; Carlo Perricone; Paola Borgiani; Cinzia Ciccacci; Sara Rufini; Enrica Cipriano; Cristiano Alessandri; Francesca Romana Spinelli; Antonio Sili Scavalli; Giuseppe Novelli; Guido Valesini; Fabrizio Conti
Journal:  J Immunol Res       Date:  2015-12-21       Impact factor: 4.818

Review 9.  Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.

Authors:  Timothy A Gottschalk; Evelyn Tsantikos; Margaret L Hibbs
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561

10.  Multi-cell type gene coexpression network analysis reveals coordinated interferon response and cross-cell type correlations in systemic lupus erythematosus.

Authors:  Bharat Panwar; Benjamin J Schmiedel; Shu Liang; Brandie White; Enrique Rodriguez; Kenneth Kalunian; Andrew J McKnight; Rachel Soloff; Gregory Seumois; Pandurangan Vijayanand; Ferhat Ay
Journal:  Genome Res       Date:  2021-03-05       Impact factor: 9.043

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.